The Alliance for Regenerative Medicine Announces Third Annual State of the Industry Briefing

  The Alliance for Regenerative Medicine Announces Third Annual State of the
                              Industry Briefing

- Event takes place on January 8, 2013 in San Francisco -

PR Newswire

WASHINGTON, Dec. 18, 2012

WASHINGTON, Dec. 18, 2012 /PRNewswire/ -- The Alliance for Regenerative
Medicine (ARM), the international organization representing the interests of
the regenerative medicine community, today announced that the third annual
State of the Industry Briefing will take place on January 8, 2013 in San
Francisco.

The session will include two panels comprised of leading experts in the field.
The first panel will provide an in-depth analysis of recent developments in
regenerative medicine, with speakers from leading companies and patient
advocacy groups. The second panel will cover the outlook for the sector from
the investor perspective, and will feature expert healthcare buy side and sell
side analysts focused on regenerative medicine and other advanced therapies.

"This is a time of terrific activity and excitement in regenerative medicine,"
said Geoff MacKay, President & Chief Executive Officer of Organogenesis Inc.,
and incoming Chairman of ARM. "The field has matured to the point where it is
fostering new innovations, while also developing unique models needed to
commercialize living technologies to reach patients. Additionally, as our
healthcare system prepares for an aging population and an increasing
prevalence of chronic diseases, regenerative medicine will play an
increasingly important role in patient care. We look forward to exploring
these issues in the State of the Industry Briefing."

Confirmed speakers include incoming ARM Chairman and State of the Industry
Briefing moderator, Geoff MacKay, President & CEO, Organogenesis, as well as
ARM Vice Chair, Keith Murphy, President & CEO, Organovo, who will moderator
the Analyst Outlook Panel. Additional panelists include Chris Calhoun, CEO,
Cytori Therapeutics; Jeffrey Jonas, President, Shire Regenerative Medicine;
Jason Kolbert, Senior Biotechnology Analyst, Maxim Group; Robert Palay, CEO,
Cellular Dynamics International; Susan Solomon, CEO, New York Stem Cell
Foundation; Matthias Steger, Global Head Research & Technology Partnering,
Roche Ltd.; Gil Van Bokkelen, Chairman & CEO, Athersys, Inc.

This event was developed by the Alliance for Regenerative Medicine (ARM), and
will be held as part of the Biotech Showcase 2013 conference taking place at
the Park 55 Wyndham in San Francisco from 8:00 a.m. to 10:00 a.m. These
sessions are open to the public and do not require paid registration for the
Biotech Showcase to attend. Space is limited for these sessions and it is
strongly recommended interested parties RSVP in advance. To learn more and to
RSVP, please visit
http://www.alliancerm.org/event/arm-state-industry-briefing. 

The Alliance for Regenerative Medicine (ARM) is a Washington, DC-based
non-profit organization that promotes legislative, regulatory, reimbursement,
and financing initiatives necessary to facilitate access to life-giving
advances in regenerative medicine. ARM also works to increase public
understanding of the field and its potential to transform human healthcare,
and provides services to support the growth of its member companies and
organizations. Prior to the formation of ARM, there was no advocacy
organization operating in Washington, DC to specifically represent the
interests of regenerative medicine companies, research institutions,
investors, and patient groups supporting more rapid adoption of technologies
in our field. To learn more about ARM or to become a member, visit
www.alliancerm.org.

Media Contact:
Michelle Linn
Linnden Communications
Phone: 508-362-3087

SOURCE The Alliance for Regenerative Medicine

Website: www.alliancerm.org